Back to Search
JAMES MCGOUGH, MD
MD
Psychiatry Physician
NPI: 1962428201IndividualAccepts Medicare
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
A46192(CA)
Child & Adolescent Psychiatry Physician
Psychiatry & Neurology — Child & Adolescent Psychiatry
Code: 2084P0804X
A46192(CA)
Education
DUKE UNIVERSITY SCHOOL OF MEDICINE
Class of 1996
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
PMID 41342306·Cochrane Database Syst Rev·2025
1-meta
Electrophysiological and Clinical Predictors of Methylphenidate, Guanfacine, and Combined Treatment Outcomes in Children With Attention-Deficit/Hyperactivity Disorder.
PMID 35963559·J Am Acad Child Adolesc Psychiatry·2023
2-rct
Methylphenidate, Guanfacine, and Combined Treatment Effects on Electroencephalography Correlates of Spatial Working Memory in Attention-Deficit/Hyperactivity Disorder.
PMID 35963558·J Am Acad Child Adolesc Psychiatry·2023
2-rct
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
PMID 36971690·Cochrane Database Syst Rev·2023
1-meta
Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study.
PMID 27453079·J Am Acad Child Adolesc Psychiatry·2016
4-observational
Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder.
PMID 27483130·J Child Adolesc Psychopharmacol·2016
4-observational
Effects of d-Methylphenidate, Guanfacine, and Their Combination on Electroencephalogram Resting State Spectral Power in Attention-Deficit/Hyperactivity Disorder.
PMID 27453081·J Am Acad Child Adolesc Psychiatry·2016
2-rct
Cognitive Effects of Stimulant, Guanfacine, and Combined Treatment in Child and Adolescent Attention-Deficit/Hyperactivity Disorder.
PMID 27453080·J Am Acad Child Adolesc Psychiatry·2016
2-rct
Pharmacogenetics of methylphenidate response in preschoolers with ADHD.
PMID 17023870·J Am Acad Child Adolesc Psychiatry·2006
4-observational
Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD.
PMID 17023867·J Am Acad Child Adolesc Psychiatry·2006
4-observational
A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD.
PMID 16481664·J Atten Disord·2006
2-rct
Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS).
PMID 17023869·J Am Acad Child Adolesc Psychiatry·2006
4-observational
Safety and tolerability of methylphenidate in preschool children with ADHD.
PMID 17028508·J Am Acad Child Adolesc Psychiatry·2006
4-observational
Adult attention deficit hyperactivity disorder is common among people in the US who are male, white, previously married, or not employed.
PMID 17065313·Evid Based Ment Health·2006
8-other
Relationship of family environment and parental psychiatric diagnosis to impairment in ADHD.
PMID 16540820·J Am Acad Child Adolesc Psychiatry·2006
8-other
Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder.
PMID 16768642·J Child Adolesc Psychopharmacol·2006
2-rct
Stimulant-related reductions of growth rates in the PATS.
PMID 17023868·J Am Acad Child Adolesc Psychiatry·2006
4-observational
Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD.
PMID 15908835·J Am Acad Child Adolesc Psychiatry·2005
3-trial
Dexmethylphenidate extended-release capsules for attention deficit hyperactivity disorder.
PMID 16026226·Expert Rev Neurother·2005
6-review
Attention-deficit/hyperactivity disorder pharmacogenomics.
PMID 15950009·Biol Psychiatry·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 MED PLZ
LOS ANGELES, CA 90095 - Phone
- (310) 825-9989
Quick Facts
- NPI
- 1962428201
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 30
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile